Leonard Mazur
2023
In 2023, Leonard Mazur earned a total compensation of $2M as Chief Executive Officer and Executive Chairman at Citius Pharmaceuticals, a 66% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,875 |
|---|---|
| Option Awards | $1,304,238 |
| Salary | $475,000 |
| Total | $1,981,113 |
Mazur received $1.3M in option awards, accounting for 66% of the total pay in 2023.
Mazur also received $201.9K in non-equity incentive plan and $475K in salary.
Rankings
In 2023, Leonard Mazur's compensation ranked 531st out of 3,006 executives tracked by ExecPay. In other words, Mazur earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 531 out of 3,006 | 82nd |
Division Manufacturing | 304 out of 1,650 | 82nd |
Major group Chemicals And Allied Products | 211 out of 918 | 77th |
Industry group Drugs | 208 out of 881 | 76th |
Industry Pharmaceutical Preparations | 130 out of 637 | 80th |
Source: SEC filing on January 26, 2024.
Mazur's colleagues
We found two more compensation records of executives who worked with Leonard Mazur at Citius Pharmaceuticals in 2023.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018